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Abstract
Renal dysplasia (RD) in dogs is a complex disease with a highly variable phenotype and mode of inheritance that does not
follow a simple Mendelian pattern. Cox-2 (Cyclooxgenase-2) deficient mice have renal abnormalities and a pathology that
has striking similarities to RD in dogs suggesting to us that mutations in the Cox-2 gene could be the cause of RD in dogs.
Our data supports this hypothesis. Sequencing of the canine Cox-2 gene was done from clinically affected and normal dogs.
Although no changes were detected in the Cox-2 coding region, small insertions and deletions of GC boxes just upstream of
the ATG translation start site were found. These sequences are putative SP1 transcription factor binding sites that may
represent important cis-acting DNA regulatory elements that govern the expression of Cox-2. A pedigree study of a family
of Lhasa apsos revealed an important statistical correlation of these mutant alleles with the disease. We examined an
additional 22 clinical cases from various breeds. Regardless of the breed or severity of disease, all of these had one or two
copies of the Cox-2 allelic variants. We suggest that the unusual inheritance pattern of RD is due to these alleles, either by
changing the pattern of expression of Cox-2 or making Cox-2 levels susceptible to influences of other genes or
environmental factors that play an unknown but important role in the development of RD in dogs.
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Introduction
Renal dysplasia (RD) in dogs is a category of disease that is not
well defined. There are numerous reports of renal dysplasia in
purebred breeds of dogs in the scientific literature, but the
spectrum of clinical symptoms is so varied that it is difficult to
precisely define this disorder [1,2]. Many breeds of dogs are
affected with RD. This has been documented in veterinary
textbooks [3] as well as case reports and articles in the scientific
literature [4–19].
Initially, there was controversy as to whether individual case
reports of this disease that seemed to fit the description of RD were
inherited or acquired [1]. Within a breed, sporadic case reports
with no family history made it difficult to determine a mode of
inheritance. Additionally dogs can present with RD at different
ages further adding complexity to the diagnosis [2]. RD in dogs
has been referred to as juvenile renal dysplasia, however, because
this disease is not limited to puppies under 2 years of age [20], we
prefer to use the term renal dysplasia (RD). For severe cases in
puppies under two years of age the term juvenile nephropathy has
also been used.
The most comprehensive study of renal dysplasia in dogs was a
ten-year study by Bovee [21], who followed a group of Shih tzu, a
breed known to have RD [19]. Wedge renal biopsy data was
collected from 52 matings and 143 dogs. Apart from the common
finding of immature fetal glomeruli, other findings from this study
included mineralization of the tubules, and diffuse interstitial
fibrosis in the cortex and medulla. Biopsies with higher
percentages of fetal glomeruli have more severe changes in other
kidney tissues. Results of this study showed that the severity of the
disease was highly variable amongst individuals. The severity of
the disease was reflected in the percentage of fetal glomeruli found
in the renal wedge biopsy. The mode of inheritance did not follow
a simple Mendelian pattern. The proposed mode in inheritance by
Bovee was autosomal dominant with incomplete penetrance.
Incomplete penetrance can be explained by variations in gene
expression or partial loss of function of a protein. For example, low
penetrance mutations in the RB1 gene (Retinoblastoma 1 gene) fall
into three classes: mutations in regulatory sequences in the
promoter, missense and in frame deletions that may result in
partial inactivation of the RB protein, and splice mutations that
could resultinareductionofmRNA levels[22].Ottersonetal.,[23]
demonstrated a link between partial loss of function mutations in
RB1 with incomplete penetrance. Other factors including modifier
genes and environment influences can also explain why individuals
having the same mutation can show a varied phenotype [24].
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16684The present study aims to determine a molecular basis of this
disease. Linkage analysis was not possible because biopsy normal
individuals could produce affected offspring. Thus we took a
candidate gene approach. The Cox-2 mouse knockout phenotype
had striking similarities with the morphological features of the
disease in dogs [25].
Cyclooxygenase, the rate-limiting enzyme in the synthesis of
prostaglandins (PGs), exists in two closely related isoforms, Cox-1
and Cox-2. Cox-1 is a constitutive form of the enzyme expressed
in most tissues [26,27], while Cox-2 [28] is an inducible form.
Although Cox-2 is generally associated with biologic events such as
injury, inflammation, and proliferation [29], the knockout mouse
model surprisingly shows abnormal kidney development.
Characterization of two knockout Cox-2 strains of mice
revealed striking similarities with renal dysplasia in dogs. In one
strain the transcription and translation start sites were deleted.
This strain gave the most severe kidney phenotype showing 100%
penetrance in -/- mice. [30]. The kidneys were severely
underdeveloped with an overabundance of immature glomeruli,
few functional nephrons and undeveloped mesenchymal tissue.
BUN (blood urea nitrogen) and creatinine were elevated consistent
with renal dysfunction. The mice had a predisposition to
secondary pyelonenephritis. In addition to the kidney abnormal-
ities there were cardiac defects in 50% of the Cox-2 -/- adult mice.
The homozygous null females were largely infertile.
The other strain disrupted the coding of sequences in exon 8 by
insertion and deleted 104 bp of sequence in this exon that are
critical for Cox-2 function [31]. This strain showed a more complex
and variable phenotype, and no heart defects were reported. The
kidneyswere small and pale.In the mildest formthe kidneys showed
immature structures consisting of immature glomeruli and tubules,
andsometimeswereaccompaniedbya thinning cortexand reduced
number of glomeruli compared to wild type. In more severe cases,
homozygotes showed tubular atrophy, interstitial inflammation and
fibrosis as well as papillary mineralization.
Further characterization of these two mouse knockout strains,
showed that Cox-2 was critical for postnatal kidney development
and function [32]. This would suggest a similar role for Cox-2 in
the dog model, as in the newborn dog differentiation of the
glomeruli is complete by 2 weeks of age, and nephrogenesis is
completed by approximately 10 weeks of age [33,34].
Recently, a mouse strain was genetically engineered to
knockdown the expression of Cox-2 [32]. This strain was
generated by the insertion of a neomycin resistance cassette
(Neo cassette) into the middle of intron 10. The kidney pathology
in this strain was compared to a genetically engineered strain that
has an active site substitution mutation that shows a severe kidney
phenotype as in the Cox-2 null strains. This knockdown strain
shows a phenotype that is intermediate between the wild type and
Cox-2 strains with severe renal pathology [35].
Cox-2 gene expression is highly developmentally regulated. In
the developing rat kidney, Cox-2 mRNA and protein are first
detected beginning at mid –gestation, and are found in the
subcapsular epithelial structures. Cox-2 expression continues
through the completion of nephrogenesis [36]. A similar pattern
of Cox-2 expression has been reported during mouse development
[37]. While the role of Cox-2 in organogenesis is not clear, this
gene shows high expression during late gestation in the skin, heart,
cartilage and the kidney in the rat [38].
The present study presents novel allelic variants in the Cox-2
promoter consisting of insertions or deletions of putative SP1
transcription factor binding sites. We discuss how these allelic
variants could influence Cox-2 gene expression, and account for
the unusual inheritance of RD in dogs.
Results
DNA sequence analysis of the canine Cox-2 gene
We DNA sequenced the entire Cox-2 gene from a clinically
affected Miniature schnauzer (27% fetal glomeruli on biopsy) and
a Standard Poodle (75% fetal glomeruli on biopsy). The coding
sequences (Genbank Accession number HQ110882) of both of
these are in 100% agreement with the public domain assembled
canine genome on Chromosome 7: 22,632,147–22,638,970. The
Poodle sample was heterozygous for allele 2, while the Miniature
schnauzer sample was homozygous for allele 1 (see below).
Using primer set 1 described in the experimental procedures, we
DNA sequenced the region immediately upstream of the ATG
translation start of the canine Cox-2 gene in clinically affected
samples from several dog breeds as well as DNA from clinically
normal dogs. This analysis revealed small deletions and insertions
of DNA sequence just upstream of the ATG start of translation
present in breeds known to have RD. Four allelic variants were
found from this analysis (compared to the wild type allele from the
canine reference genome sequences). Three of them were found in
the clinically affected samples. A forth variant, the 6 nucleotide
deletion found in allele 1 has been identified in a single Gordon
setter, a single Golden retriever sample and numerous Flat-coated
retrievers. One of the Flat-coated retrievers, a carrier of allele 4
has been identified as a presumptive case of renal dysplasia based
on blood biochemistry and urinalysis.
Figure S1A shows the allelic variants of the canine Cox-2 gene
found in RD affected individuals. Numbering of the sequence in
all alleles is given relative to the translation start. Allele 1 is a
deletion of wild type DNA sequences. Alignment of allele 1 with
the wild type sequence shows a deletion of 6 nucleotides,
CCGCCG at position -73 of the canine Cox-2 gene and a
deletion of 11 nucleotides at position -37. In addition to these two
changes there is a SNP at position -42. This is a ‘‘T’’ in the wild
type sequence and a ‘‘C’’ in allele 1. DNA from 12 different dogs
with this allelic variant was sequenced and all 12 had the ‘‘C’’
SNP.
Allelic variant 2 is an insertion of 12 nucleotides starting at
position -78 of the canine Cox-2 gene (CGCCTCCGCCTC). 7
dogs with allelic variant 2 were sequenced. None of these had the
SNP described in allelic variant 1.
Allelic variant 3 is an insertion of 24 nucleotides at position -78
of the canine Cox-2 gene (CGCCTCCGCCTCCGCCTCCG-
CCGC). The first 12 nucleotides of this 24 nucleotide insertion is
the insertion in allelic variant 2. Four dogs with this allele were
DNA sequenced, and none contained the SNP of allelic variant 1.
Allele 4 is the 6 nucleotide deletion at position -73 found in
allelic variant 1. Allele 4 contains the ‘‘C’’ SNP at position -42.
Figure S1B shows electrophoretic separation of the 5 different
alleles.
Pedigree analysis from a family of Lhasa apsos
RD is very common in dogs of the Lhasa apsos breed [19], so
we performed a pedigree study from a family of Lhasa apsos along
with biopsy data and genotype information (Figure S2). In some
cases the genotype had to be inferred from the parents. Dogs with
inferred genotypes are marked with either a?, or the possible
genotypes are given. A total of 52 dogs are included in the
pedigree. Of these 35 were biopsied. Sixteen of the biopsied
animals had #10% fetal glomeruli. These dogs had no signs of
kidney impairment. Seven dogs had .10% fetal glomeruli. Three
of these dogs had greater than 35% fetal glomeruli and died from
renal failure between 5 and 10 years of age. One of these died at 6
months of age from chronic renal failure, and was diagnosed with
Cox-2 Allelic Variants and Renal Dysplasia in Dogs
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biopsy.
A mating from two biopsy normal parents produced a biopsy
positive female. The sire in this case was homozygous for mutant
allele 2 and the dam was heterozygous wt/allele2. The biopsy
positive puppy was heterozygous wt/allele2.
There were 35 Lhasa apsos in this family with both genotypic
and biopsy data. Of these 34 carried at least one of the mutant
alleles, 25 had biopsy findings consistent with renal dysplasia, and
9 had normal biopsy results. The other individual was homozy-
gous for wild type alleles and had a normal renal wedge biopsy.
Importantly, the mutant alleles are statistically correlated to the
renal dysplasia phenotype (X
2=15.2, p,0.001).
Of Lhasa apsos in this family that were homozygous for mutant
alleles, 14 were diagnosed with renal dysplasia on biopsy, and 6
were normal. Of those that were heterozygous with one mutant
allele and one wild type allele, 6 were diagnosed with renal
dysplasia on biopsy, and 2 were normal. There was no statistical
difference in the frequency of renal dysplasia between Lhasa apsos
that were homozygous or heterozygous for mutant alleles
(X
2=0.07, p.0.5).
Taking all of this data into account, in this family approximately
60% of dogs that are either carriers, or homozygotes for mutant
alleles 2 or 3 have some aspect of abnormal kidney pathology. Of
these approximately 10% have clinical signs of kidney disease
which in this example reduced the life span of three, and one died
as a puppy. 40% have a normal biopsy, but can produce biopsy
positive offspring. These data show a dominant mode of
inheritance of these alleles with incomplete penetrance and
variable phenotypic expression.
Association of RD with clinical cases in purebred breeds
Apart from the specific examples mentioned above we
genotyped clinical samples from 17 other breeds that met the
criteria for inclusion in this study as listed in the methods and
materials section. Table 1 shows the genotype of clinical cases of
RD in various breeds. All cases contained one or two copies of a
mutant allele. In some of the cases, the genotype was inferred from
the parents. No dogs affected with renal dysplasia were identified
with a homozygous wild type genotype. Therefore these allelic
variants in the canine Cox-2 gene are associated with this disease
in these breeds. Table 2 summarizes the results of these findings
from the cases with an unequivocal genotype.
German shepherd dog analysis
We were unable to find any cases of RD in the German
shepherd dog population in the scientific literature. However a few
cases were recently identified in the population in Great Britain.
We obtained the pathology reports for two littermates that were
under 6 months old. The diagnosis was Juvenile nephropathy, a
term which is equivalent to renal dysplasia. Of twenty random
dogs tested for the mutation, one carrier of mutant allele 1 was
identified. The sire of this dog was one of the animals that had
produced RD affected puppies, and was inferred as having at least
one copy of mutant allele 1 based on examination of the
remainder of the littermates of the carrier dog that was identified.
These had puppies that were carriers of allele1 and homozygotes
of allele1. The rest of the German Shepherds in this initial survey
tested as wt/wt. Subsequently, another 65 German Shepherds
were tested in order to determine the frequency of mutant alleles
in this breed.
Only mutant allele 1 was found in this population and the
frequency of this allele was 8% (Table 3).
A case study in English cocker spaniels
Familial Nephropathy (FN) is a juvenile-onset fatal kidney
disease, which has been well documented in the English cocker
spaniel breed and is caused by a conserved mutation in the canine
COL4A4, gene [39]. This mutation is inherited as a recessive trait.
Affected individuals show a distinctive ultrastructural lesion in the
glomerular basement membranes.
There have been recent reports of RD in English Cocker spaniels
[40]. We were able to obtain DNA from a formalin preserved
kidney sample from an RD affected English cocker spaniel. The
affected puppy tested as homozygous for mutant allele 1. Both
parents of this puppy were genotyped as clear for FN.
Breed statistics
Table 3 summarizes the frequency of the Cox-2 mutant alleles
in various breeds for which there were sufficient number of dogs
tested.
Discussion
The molecular basis is renal dysplasia in dogs has been elusive
because of the unusual mode of inheritance and highly variable
phenotype coupled with the difficulty in obtaining samples from
owners who are willing to have their dogs undergo an invasive
procedure for diagnosis. In this study we chose to examine the
canine Cox-2 gene for mutations based its role in kidney
development in the mouse. We show that allelic variants in the
canine Cox-2 promoter are associated with the disease, and
postulate how these DNA sequences could influence the
expression of Cox-2 thereby explaining the mode of inheritance,
and variable phenotype.
Perhaps the most surprising result from the characterization of
Cox-2 knockout strains of mice was the presence of dysplastic
kidneys consisting of embryonic tissue types. There are two related
Cox-2 genes in the mouse that participate in the synthesis of
prostaglandins. The Cox-1 isoform is expressed constitutively,
while Cox-2 is inducible in response to inflammation following
exposure to growth factors, lymphokines, or other mediators of
inflammation [41], and promotes this process. Therefore, it
seemed unusual that this gene would be so critical in development.
However, after the initial characterization of the Cox-2 knockout
mouse strains Cox-2 was shown to be highly expressed in the
kidney during late gestation in the rat, reinforcing the role of Cox-
2 in kidney development [38].
The dog RD model shares morphological features with both of
the Cox-2 knockout mice strains The pathology seen in the dog
model shows immature glomeruli and tubules in mild cases, and in
severe cases, a thinning cortex, interstitial fibrosis and inflamma-
tion as well as mineralization of the tubules. As in the mouse
model in severe cases the kidneys appear small and pale.
These similarities in the phenotype of renal dysplasia between
mice and dogs prompted us to look for mutations in the canine
Cox-2 gene.
Here we report small insertions and deletions just upstream of
the ATG translation start site of the canine Cox-2 gene associated
with RD. All of the mutant alleles are inherited as dominant with
incomplete penetrance (see Figure S1 and Table 1). These alleles
were shown to have 100% correlation with clinical cases of RD in
19 breeds. Therefore, this research suggests a similar conserved
role of Cox-2 during kidney development in the dog.
The breeds with the highest incidence of RD had the highest
frequency of mutant alleles while as expected the breed with the
lowest frequency of mutant alleles also has the lowest incidence of
disease (Table 2).
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RD is dominant with incomplete penetrance, through extensive
pedigree analysis of a family of closely related Lhasa apsos, and
clinical samples from many breeds of dogs. The percentage of RD
individuals in this family was approximately 10%. This is
consistent with the finding of Bovee [21] who estimated that the
penetrance in the Shih Tzu breed was between 5 and 10%. Before
this study, Bovee was able to prove a dominant mode of
inheritance by an outcross breeding of a Shih Tzu with 2% fetal
glomeruli with a normal Poodle mix resulted in a litter with all
being affected (4–l0% fetal glomeruli). One of our clinical cases
was an F1 Goldendoodle (the dam was a Golden retriever, and the
sire was a miniature poodle). This confirms the finding of the
outcross from the Bovee study. A mode of inheritance that is
dominant with incomplete penetrance allows for a high frequency
mutant alleles as seen in this pedigree.
The focus of mutation research has recently shifted to looking for
disease causing mutations in the non- coding regions that regulate
gene expression [42]. This is largely due to recent advances in
genomics including extensive SNP maps and genome-wide
association studies (GWAS). Scientists have increasingly been
looking for mutations in promoter and regulatory region of genes
identified bylinkageorGWASincases wherethe biology ofsuitable
candidate genes relates to the phenotype but there are no disease
causing mutations in the coding regions [43]. In the present study,
the unusual mode of inheritance including low penetrance
suggested that candidate gene analysis was more appropriate than
linkage or GWAS. Not only does the biology of Cox-2 in kidney
development support our hypothesis that these promoter allelic
variants are responsible for RD in dogs, but the fact that the
mutations are located just upstream of the ATG translationstart site
justifies the mode of inheritance strengthens our argument as
mutations that are dominant with incomplete penetrance, can be
mutations in regulatory sequences. From the few well studied
Table 1. Genotypes of RD clinical samples from various breeds.
Case # Breed Diagnosis Genotype Comments
1 Poodle Biopsy + Allele 2/WT Deceased from RD-75% fetal glomeruli
2 Poodle Biopsy + Allele2/WT 5% Fetal glomeruli
3 Shih tzu Biopsy + Allele1/WT Deceased from RD,6 months
4 Gordon setter Biopsy + Allele1/WT Deceased from RD
5 Gordon setter Biopsy + Allele2/WT
6 Tibetan terrier Necropsy Allele1/WT Deceased from RD
7 Tibetan terrier Ultrasound Allele2/Allele2
8 Miniature schnauzer Biopsy + Allele1/Allele1
9 Boxer Ultrasound Allele3/WT Deceased from RD
10 Bernese mountain dog Necropsy Allele3/WT or Allele3/3 Progeny produced [2] –one was carrier
Allele 3: one homozygous Allele
3- genotype inferred from parents
11 Portuguese water dog Ultrasound Allele3/wt
12 Bichon Frise Ultrasound/Biopsy Allele3/wt
13 Australian shepherd Necropsy Allele2/Allele2 Deceased from RD
14 Shetland sheepdog Ultrasound/blood biochemistry Allele2/Allele2
15 Labrador retriever Ultrasound Allele2/Allele3 Deceased from RD
16 Yorkhire terrier Necropsy Allele3/wt Deceased from RD
17 Soft –coated wheaten terrier Ultrasound/necropsy Allele3/Allele3 or
Allele3/Allele2
Genotype of parents: sire
Allele3/Allele3Dam: Allele3/Allele2
18 Soft –coated wheaten terrier Necropsy Allele3/Allele3 or Allele3/wt Dam: Allele3/Allele 3
19 Soft –coated wheaten terrier Necropsy Allele3/wt or Allele2/wt Dam: Allele2/Allele3: Sire: wt/wt
20 Airedele terrier Biopsy Allele3/Allele3- Deceased from RD- genotype
inferred from parents
21 Goldendoodle F1 cross Biopsy/ultrasound Allele1/Allele3 - Deceased from RD – genotype
inferred from parents
22 Rottweiler Ultrasound Allele2/Allele2
Animals whose genotype was inferred from the parents are noted in the comments.
doi:10.1371/journal.pone.0016684.t001
Table 2. Summary of results from clinical cases with
unequivocal genotype.
Genotype #Cases
1/wt 3
2/wt 4
3/wt 3
1/1 1
2/2 4
2/3 1
2/3 1
wt/wt 0
doi:10.1371/journal.pone.0016684.t002
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confirmed, and in all these cases examples the DNA sequences that
are disrupted or mutated are transcription factor binding sites [43].
Recently researchers have discovered that random fluctuations
in gene expression caused by a mutation in a tightly regulated
developmental pathway can also lead to incomplete penetrance by
upsetting stable and buffered gene expression in a wild type
background [44]. As a result of these fluctuations, certain genes in
the pathway fail to reach the threshold for completion of
development. Given that Cox-2 is highly developmentally
regulated, it is conceivable that these allelic variants could upset
the balance of gene expression in a developmental pathway as
described above. If this were true, RD would be considered a
monogenic trait. Accordingly, since these mutations are behaving
the same in different breeds of dogs, and therefore different genetic
backgrounds, this model could apply to the Cox-2 allelic variants
presented in this research.
Presumably, since the mouse knockout model constitutes a null
mutation for the mouse Cox-2 gene and results in a phenotype
that is similar to the canine RD model, it is likely that the changes
in the promoter region of the canine Cox-2 results in reduced
amounts of Cox-2 protein. Therefore, the most likely consequence
of these variants is down regulation of gene expression. All of the
allelic variants presented in association with RD involve potential
SP1 transcription factor binding sites, either an SP1 site deletion or
insertion of a VNTR (variable number of tandem repeat) motif
containing multiple SP1 sites. The Sp1 transcription factor is a
ubiquitously expressed, zinc finger containing DNA binding
protein [45].
In one allele, there is a deletion of CCGCCCGCGCT at
position -37. We identified a conserved sequence, CCCGCG,
within this deletion by comparing the promoter regions of the dog,
cow and horse Cox-2 genes. This sequence is a potential SP1
binding site. On further examination of the canine Cox-2 gene, we
were unable to identify a TATA box. Often promoters that are
lacking a TATA box contain multiple SP1 sites [46,47], and this is
the case for the canine Cox-2 gene. The other deletion in allele 1 is
CCGCCG at position -73 is also a putative SP1 transcription
factor binding site. This second deletion at position -73 is also
found in allele 4. We identified this allele in a Gordon setter,
Golden retriever, and several Flat-coated retrievers. One of the
Flat-coated retrievers was presumed to be a case of RD based on
blood biochemistry and urinalysis. We need to obtain additional
clinical samples from this breed that have been diagnosed with RD
by the inclusion criteria for this study in order to determine if this
allele is also associated with the disease. Since SP1 is an activator
of transcription [45], the deletion of an SP1 site should result in
down regulation of gene expression.
The other two alleles that are associated with RD are multimers
of the sequence GCCTCC. Again, this is a putative SP1 binding
site.
While it is obvious that deletion of an SP1 transcription factor
binding site could result in down regulation of Cox-2 as in the case
of allelic variant 1 there is also justification that the insertion of
multiple SP1 sites could also result in down regulation (allelic
variants 2 and 3). There are examples in human disease of
associations of variable number of tandem repeats (VNTR)
polymorphisms containing SP1 binding sites in the promoter
region [48,49]. These examples are analogous to allelic variants 2
and three. In one such example a VNTR in the promoter of the
human X-ray repair cross-complementing 5 (XRCC5) gene is a
risk factor for bladder cancer. In vtiro transcription assays of the
VNTR polymorphism from the XRCC5 gene showed that higher
number of repeats gave lower gene expression. These authors
postulated that while SP1 is generally thought of as a
transcriptional activator, it can also function as negative regulator
of gene expression, and that multiple copies of SP1 binding sites in
the VNTRs in the promoter could result in lower gene expression.
We performed relative RT-PCR the levels of Cox-2 from
kidney samples from adults with RD (data not shown). These were
from dogs with severe cases of RD (75%FG, 35%FG and 44%FG).
The results were initially surprising in that Cox-2 expression in the
normal adult kidney is barely detectable [50], and in these clinical
samples there were very high levels of Cox-2 expression. However
given that inflammation is a part of this disease process [20], it was
unclear if Cox-2 expression was in response to this, or was a
consequence of the allelic variants. Clearly in vitro expression data
would be needed to elucidate the effects of the insertions in allelic
variants 2 and 3 on fetal Cox-2 expression, but this is beyond
scope of this study. Studies involving promoter mutation are scarce
because the studies that define the relationship between the
mutation and the disease are laborious and the effect of this class of
mutation can be subtle [43].
The biopsy study presented in the family of Lhasa apsos re-
emphasizes the focus of this disease. Many veterinarians and dog
breeders have in the past viewed RD as a disease of young puppies
and havefocused their attentionon these cases.Thisis why theterm
juvenile renal dysplasia has become so pervasive. It seems obvious
thatthiswouldbethecase asthesedevastatingcasereportsaremore
likely to be reported to the breeder and noticed by veterinarians, as
it is unusual to consider kidney failure of a dog between 5 and ten
years of age to be a developmental defect. The pedigree study in
Lhasa apsos highlights this issue in that three individuals in this
pedigree with greater than 35% fetal glomeruli died of renal failure
later in life. One individual with .40% fetal glomeruli died at 8
years of age. If this animal had not had a renal wedge biopsy as a
Table 3. Frequency of the mutant alleles in various breeds.
Breed #tested WT Allele1 Allele2 Allele3 Allele4 Frequency mutant alleles
Miniature Schnauzer 184 36 329 0 3 0 90%
Lhasa apso 82 27 2 73 62 0 84%
Poodle 219 154 40 234 10 0 64%
Shih tzu 93 78 91 0 17 0 59%
Boxer 208 268 84 1 63 0 36%
Shetland sheepdog 75 100 0 46 4 0 33%
German Shepherd 85 156 14 0 0 0 8%
doi:10.1371/journal.pone.0016684.t003
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of this disease. Therefore, this research highlights the importance of
wedge biopsy data in the true diagnosis of RD. This research
howeverprovidesatoolforthe breedingmanagementofthisdisease
in canine populations that exist today.
Given the mode of inheritance a specific DNA-based genetic
test is necessary for disease management in many canine breeds.
Before the development of this genetic test diagnosis of RD was by
wedge biopsy, an invasive procedure. However, even with this,
biopsy negative animals have been shown to produce RD affected
progeny as shown in this study, and the study of Bovee [21].
Therefore successful management and elimination of this disease is
only possible with a diagnostic test. These autosomal dominant
alleles are statistically associated with susceptibility to develop RD.
While it is not known what other genetic and/or environmental
factors must also be present for the development of RD, genetic
testing for these mutant alleles can assist those with breeds and
families at high risk of developing clinical disease.
Materials and Methods
DNA sequencing of the canine Cox-2 gene from clinical
cases of RD in various breeds
Primers from the canine Cox-2 gene (reference sequence:Chro-
mosome 7: 22,632,147-22,638,970) were chosen from the
upstream promoter region and sequences flanking the 10 exons.
These were used to directly amplify the upstream region and
coding sequences of the canine Cox-2 gene. Standard PCR
conditions were used for all of the fragments except for the
upstream regions, which are GC rich, and required the addition of
1 X Hi-spec buffer (Bioline). PCR fragments were directly
sequenced by Eurofins| MWG| Operon of Huntsville AL.
The following primer sets were used to amplify the canine Cox-
2 gene:
Set1:59UTR-exon1-part of intron1:59 - TTG TCA AAC AAC
TTG CAG CGA GCG - 39 (forward) 59 - ATC ACC CAG CCG
AGG AGT C – 3 (reverse).
Set 2: Exons 2 and 3 and flanks: 59 - CCT GGT TGA ACG
TTG TTG GCC TTA - 39 (forward): 59 - CCC ACT CAG GTT
CAT TCT CTC A - 39 (reverse).
Set 3: Exon 4 and flanks: 59 - CCA TGG ACC ACT GGT
TTA CAA TAG G - 39 (forward): 59 -(forward): GAG ATT CAC
AGA TAT CCT CAA GCA - 39 (reverse).
Set 4: Exon 5 and flanks: 59 - CTC CTG TAA GTG AAG AAA
GCC C - 39 59 - CTC CTG TAA GTG AAG AAA GCC C - 39
Set 5: Exon 6 and 7 and flanks: 59 - ACT ATT TAG TGG
TTG TGA GAG AAA CG - 39 59 -(forward): AGT AAC ATG
CCA GCT TTC TCT GGG - 39 (reverse).
Set 6: Exon 8 and flanks: 59 - ACA AGA TTG CAT TTC AGT
TGC TTG - 39 (forward): 59 - CAG AAA GAT CAC TTT GGT
GGC AGA - 39 (reverse).
Set 7: Part of Exon 9 intron 9 and part of exon 10: 59 - GCA
TTA GTC TTC CCT CCT TTG TAC CC - 39 (forward):- ACC
ATG GTC TCA CCA AAG ATG GCA - 39 (reverse).
Set 8: EXON 10 and flanks: 59 - GTT GAA AGG GAA TTG
AGC AAA GGG - 39 (forward): 59 - CAG GCT TCT ATA GTT
CAG TTG ACC G - 39 (reverse).
PCR conditions for a direct DNA test for RD susceptibility
DNA was isolated from buccal swabs by the method of Richards
et al., [51].
The primers used to amplify all of the alleles were:59 - ACA
GCG CCT GCC TCC TCC A - 39 (forward): 59 - AGG TAC
CCA CCT GCG CGG ACG A - 39 reverse. These primers
surrounded all of the mutant alleles and therefore diagnosis was
done in a multiplex PCR reaction. Conditions for this were as
follows: one cycle at 95uC for 5 minutes followed by 5 cycles of
95uC3 0s ,5 4 uC for 30 s, and 72uC for 30 s. A further 30 cycles
were performed as follows: 95uC for 30 s, 57uC for 30 s and 72u
for 30 s. A final cycle of 72u for 5 minutes completed the PCR.
The cycles at the lower temperature were necessary for Allele 3
would sometimes drop out of the reaction at the higher
temperature. Standard PCR conditions were used with the
addition of 1 X Hi-spec additive (Bioline). This was added due
to the GC content of this fragment. The optimal primer
concentration was 1 uM.
Collection of wedge biopsy data from a Lhasa apso
family
All biopsies done on the Lhasa apso family were sent to the
University of Pennsylvania, School of Veterinary Medicine,
Laboratory of Pathology, 3800 Spruce Street, Philadelphia, PA
19104-6051 For consistency, a single pathologist, Dr. Michael
Goldschmidt, read the results.
Collection of clinical samples from various dog breeds
Owners of animals diagnosed with RD submitted buccal swab
samples along with a transfer of ownership and release document
for the DNA. The breeds that were included are listed in Table 1.
Inclusion criteria for the study
Dogs included in the study either had a biopsy or necropsy
diagnosis of RD, or an abnormal kidney ultrasound consistent with
RD.
Participant Requirements
Participants submitting DNA samples and clinical information
were required to sign a transfer of ownership and release
document for the materials submitted. The owners who provided
renal wedge biopsy data did so voluntarily. All renal wedge
biopsies preformed by a licensed veterinarian practitioner of their
choice.
Supporting Information
Figure S1 Allelic variants in the Cox-2 promoter. (A)
Allelic variants in the Cox-2 promoter, just upstream of the ATG
translation start site. Allelic variant 1 has DNA sequences that are
deleted and are boxed with the number 1 below the box. Allelic
variants 2 and 3 are insertions of sequence. Allele 2 is underlined
and not shaded. Allele 3 is a further insertion of sequences at
nucleotide -78 relative to the ATG start, and is a duplication of the
inserted sequences in allele 2. Allelic variant 4 is a deletion of 6
nucleotides CCGCCG and is boxed and marked with the number
4 below the box. (B). Gel separation of the Allelic variants of the
canine Cox-2 gene. Lane 1 is the 100 bp maker (New England
Biolabs); Lane 2, 3, 4, 5 are allelic variants, 1, 2, 3 and 4. Lane 6 is
the wild type allele. The DNA was separated on a Spreadex-400
pre-cast gel (Elchrom scientific), using 1 X TAE buffer. The gel
was run at 150 V for one hour followed by an hour at 100 V.
(TIF)
Figure S2 Pedigree analysis of a family of Lhasa apsos.
The symbols shown in the pedigree are given at the bottom of the
figure. The genotype of the dogs in the pedigree was determined
either directly or by inference. Where two genotypes are possible
by inference, both are listed.
(TIFF)
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